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Abstract
Objective To study the clinical profile and outcome of
children screened and diagnosed for Swine flu at a tertiary
care hospital.
Methods All Children with suspicion of swine flu infection
attending our hospital during the epidemic from August
2009 through January 2010 were screened and categorized
into A, B and C as per guidelines of National Health and
family welfare. Patients in Category A were advised home
quarantine, Category B tested and treated with ostelamivir
and Category C were hospitalized.
Results Among 424 cases screened for Swine flu, 79 were
children in the age group 0–12 years of age (18.6%). The
median age of presentation was 5 years. Children belonging
to Category A were 43(54.4%), Category B were 31
(39.2%) and Category C were 5(6.3%). Out of the cases
that were screened, 19 children were confirmed positive for
H1N1 infection(30.2%).Out of positive cases 8 were in
category A (42%), eight were in category B (42%) and five
were in category C (26.3%).
Conclusions During the epidemic of swine flu at puducherry,
majority of cases were category A with mild symptoms.
Home quarantine and preventive measures during the
epidemic were found to be far more important than testing
and treating with Oseltamivir.
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Introduction
Swine origin influenza was first recognized in the border
area of Mexico and United States in April 2009 [1]. The
currently circulating strain of Swine origin influenza virus
of the H1N1 strain has undergone triple ressortment and
contains genes from the avian, swine and human viruses
and is known for the rapidity with which it spreads to the
community [2]. The diagnosis is based on the RT-PCR,
viral culture or increasing neutralizing antibodies. Princi-
ples of treatment consist of isolation, universal precautions,
good infection control practices, supportive care and use of
antiviral drugs [3]. We present the clinical profile of
suspected cases of swine flu infection among children
attending our hospital.
Material and Methods
All the cases with suspicion of swine flu influenza virus
from August 2009 through January 2010 were screened.
The diagnosis was confirmed by collecting throat Swabs
and doing RT-PCR for H1N1. History of close contact with
a confirmed case of swine influenza A (H1N1) or recent
travel to an area confirmed cases was recorded. All the
cases screened were categorized as per guidelines of
National Health & family welfare and WHO into category
A, B and C [4].
Category A
Comprisedofchildren withmildfeverpluscough/sorethroat
with or without body ache, headache, diarrhea and vomiting.
They did not require oseltamavir and were given symptom-
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DOI 10.1007/s12098-010-0198-7atic therapy. They were monitored for their progress and
reassessed after 24–48 h and advised home quarantine
Category B
B1 comprised of children who was subdivided into B1
and B2 categories. In addition to all the signs and
symptoms of category A if there were symptoms of
high grade fever and severe sore throat, he/she was put
on home isolation and treated with oseltamivir.
B2 comprised of children who in addition to the
symptoms of category A, were <5 years age, had
chronic systemic illness, Immunosuppressed condi-
tions like steroid therapy, nephrotic syndrome, HIV/
AIDS and were given oseltamavir [4].
Category C
Comprised of children who in addition to the Category A
and B symptoms, developed breathlessness, chest pain,
drowsiness, hypotension, sputum mixed with blood, cya-
nosis, irritability, refusal to accept feeds and worsening of
underlying chronic conditions. Such patients immediately
admitted and tested for H1N1 and treatment started. All
close contacts of confirmed cases and health care personnel
were given chemoprophylaxis for a period of 10 days from
the last exposure as per the guidelines of Ministry of Health
and Family welfare [4].
Results
During the period of epidemic from August 2009 through
January 2010, 424 cases were screened for swine flu. Out
of which 79 were children in the age group of 0–12 years
(18.6%). There was no significant sex predominance
among children (Table 1).
Children in category A were 43(54.4%), Category B 31
(39.2%) and Category C were 5(6.3%). The number of
suspected cases that were given oseltamivir were 55(69.6%)
and among them 19(34.5%) belonged to Category A, 31
(56.36%) belonged to Category B and 5(9.0%) belonged to
Category C. Samples were collected from 63(79.7%) and out
of which 19 were H1N1 positive (30.2%). Among positive
cases 8 were in Category A (42%), eight in Category B
(42%) and three in Category C (15.7%). Out of 79 cases, nine
had history of contact with swine flu positive cases, of which
three tested positive. Out of the total 19 cases proved to be
swine flu positive, 16 were indigenous cases. One death
occurred among those who were screened for swine flu, but
he tested negative for H1N1 (Table 2).
Fever(97.4%),cough(96.2%),coryza(96.2%)andmyalgia
(82.2%) were the predominant symptoms. Other symptoms
weresorethroat(29.1%),headache(20.3%),vomiting(18.9%)
andbreathlessness(8.8%).Lesscommonsymptomswerejoint
pains (6.3%), diarrhea (5.0%) and stridor (1.3%) (Table 3).
Discussion
The 2009 swine flu pandemic is a global outbreak of novel
H1N1 strain and was first recognized in the state of
Veracruz, at the border between Mexico and United states
in April 2009, and during a short span of two months
became the first pandemic of the 21st century. This
outbreak involved more than 170 countries spread over all
the continents with more than one lakh affected people [5].
The reason for the rapidity of spread is because many
people have mild symptoms and never seek treatment and
those who get treatment don’t officially get tested and many
times it is only the hospitalized patients who get tested [6].
In India, the first case reported was from pune and the
pandemic has spread quite rapidly with more than 2,000
Table 1 Age and sex distribution
Age Male Female Total
0–12 months 9 8 17
1–6 yrs 11 15 26
7–12 yrs 20 16 36
Total 40 39 79
Table 2 Categorization of cases
Category Cases (%) H1N1 positive (%)
A 43(54.4) 8(18.6)
B 31(39.2) 8(25.8)
C 5(6.3) 3(60)
Table 3 Signs and symptoms in screened cases
Symptoms Total Percentage (%)
Fever 77 97.4
Cough 76 96.2
Coryza 76 96.2
Myalgia 65 82.2
Sore throat 23 29.1
Headache 16 20.25
Vomiting 15 18.9
Respiratory distress 7 8.8
Diarrhea 4 5.06
Joint pain 5 6.3
Stridor 1 1.26
1094 Indian J Pediatr (2010) 77:1093–1095confirmed cases equally affecting both sexes with 25 deaths
in the initial phase of the epidemic itself. Children and
Young adults were commonly affected and nearly 40% of
those affected have been children less than 14 yrs [7].
Swine flu is transmitted by droplets or fomites and the
incubation period is 2 to 7 days. Most of them present with
mild symptoms in the form of fever, cough, sore throat,
headache, joint pain and myalgia [8]. A feature seen more
frequently with swine flu origin influenza is gastrointestinal
symptoms with, almost one fourth of them presenting with
vomiting and diarrhea. Unusual symptoms reported are
conjunctivitis, parotitis, and hemophagocytic syndrome [9].
Less than 10% of Children present with severe manifes-
tations in the form of pneumonia and respiratory failure and
need hospitalization [10]. Patients at risk of developing
severe disease include age less than 5 years, chronic
systemic illness, on steroids or immunosuppressive therapy.
Children younger than 2 years have the highest complica-
tion rates. Antiviral drugs effective against H1N1 virus
include oseltamivir and Zamanavir and with good support-
ive care the case fatality is less than 1% [11, 12].
The preventive measures include: social distancing,
prevention of the spread of infection in schools, practicing
respiratory etiquette, use of facial masks, hand hygiene and
use of chemoprophylaxis with antiviral drugs [13, 14]
In our hospital, 18.6% of the total cases screened were
children and majority of them presented with mild
symptoms and 6.3% with severe symptoms requiring
hospitalization. The number of suspected cases given
oseltmavir was 69.6% and most of them had B2 symptoms.
Sixteen of the nineteen cases, that were tested, were
indigenous cases. The most important source of infection
is at schools, public places and gatherings. Throat swab was
taken in 79.7% of suspected cases which yielded positivity
in 30.2%. So, most children with flu symptoms do not need
a test for pandemic H1N1/09 especially since the test
results do not affect the recommended course of treatment
[15, 16]. There were no deaths in children with confirmed
H1N1 infection in our hospital. This was quite contrary to
pattern present in other parts of the country where the
percentage of positive cases and deaths were more in
children and young adults.
Conclusions
All the cases of suspected swine flu infection don’t require
treatment. Home quarantine, hand hygiene and early
referal to the hospitals especially with severe symptoms
are more important than the treatment itself. Proper travel
precautions, active vigilance in schools and work place and
proper use of the facial masks may help in controlling the
rapid spread of swine flu.
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